Don't forget clinical trial result for chronic respiratory disease management screening for COPD (and likely Asthma next), since they are screening device, would they still need to go through the time consuming regulatory approval process?
RAP Price at posting:
25.5¢ Sentiment: Buy Disclosure: Held
